The patients will be monitored for 12 months at three Centers of Excellence in Northern Italy.

At the starting blocks is the prospective observational clinical study on patients with traumatic and complete spinal cord injury in the acute phase. They will be observed for 12 months during their neurorehabilitation journey. Authorized by the respective Ethics Committees, the study has commenced with patient recruitment at the Niguarda Metropolitan Hospital in Milan, the Villa Beretta Neurorehabilitation Center in Lecco, and the Papa Giovanni XXIII Hospital in Bergamo.

This marks Hemera’s entry into the clinical phase, aiming to monitor the physiological evolution of the disease in patients for a year post-trauma. The goal is to gain a detailed understanding of spinal injuries and the progression of severe post-traumatic conditions for the benefit of the scientific-clinical community. Additionally, the study aims to collect clinical data in support of the subsequent pharmacological intervention study scheduled to commence in 2025.